It is currently Mon Dec 22, 2014 1:32 pm

News News of Copaxone

Site map of Copaxone » Forum : Copaxone

A board to discuss the Multiple Sclerosis modifying drug Copaxone

3x weekly Copaxone dosing receives pelminary positive......

Thrice-weekly Copaxone dosing receives pelminary positive outcome in Europe

Teva Pharmaceutical Industries Ltd. announced that its thrice-weekly Copaxone® (glatiramer acetate) 40mg/ml treatment for relapsing-remitting multiple sclerosis (RRMS) has received positive results in a decentralized procedure. The favourable outcome proceeds a Positive Assessment Report from the United Kingdom, the Reference Member State’s Medicines and Healthcare Products Regulatory Agency (MHRA), and all Concerned Member States (CMS) in Europe that had participated in the procedure. The company is ...
Read more : 3x weekly Copaxone dosing receives pelminary positive...... | Views : 217 | Replies : 0


Copaxone moves toward Japanese regulatory approval

Teva Pharmaceutical Industries Ltd. multiple sclerosis treatment Copaxone is progressing toward regulatory approval in Japan. At the end of 2013, Teva reported a development and marketing agreement with Japan's Takeda Pharmaceutical Co. Ltd. for the Japanese market.

At the time, Teva said that regulatory approval was expected to be received in less than a year. However, nearly a year has passed and no approval has been received......... Read More - http://www.ms-uk.org/copaxone
Read more : Copaxone moves toward Japanese regulatory approval | Views : 284 | Replies : 0


i switched meds and now i have many boxes of copaxone

does anyone want them? i have one box that expires at the end of next month and the rest are all in 2015. i'm in the bay area and if you live somewhat close or are local that would be ideal, but mostly i just want someone to make good use of them. PM for more details.
Read more : i switched meds and now i have many boxes of copaxone | Views : 524 | Replies : 2


Copaxone therapy remodels the composition of B-Cells

The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple Sclerosis.

Sara J. Ireland, BA; Alyssa A. Guzman, BS; Dina E. O’Brien, BS; Samuel Hughes; Benjamin Greenberg, MD; Angela Flores, MD; Donna Graves, MD; Gina Remington, BSN, RN; Elliot M. Frohman, MD, PhD; Laurie S. Davis, PhD; Nancy L. Monson, PhD.

Abstract

Importance: This study describes what is, to our knowledge, the previously unknown effect of glatiramer acetate ...
Read more : Copaxone therapy remodels the composition of B-Cells | Views : 376 | Replies : 0


Skipping a Shot Once a Week

My insurance is refusing to pay for the new dosage of Copaxone of 40 mg. 3xwk. Since my skin is a mess (and I rotate!) and I am running out of shot sites, I have been skipping one shot a week for about three months. It adds up to the same amount of medicine I would be getting if I were able to get the new dosage. Now I am in relapse, but I don't ...
Read more : Skipping a Shot Once a Week | Views : 476 | Replies : 5


First generic medication for MS developed

New study finds a generic version of Copaxone to be just as effective, safe.

A new study on the first generic medication for Multiple Sclerosis is showing promising results when compared to the widely-used name brand medication, Copaxone...... Read More - http://www.ms-uk.org/copaxone
Read more : First generic medication for MS developed | Views : 386 | Replies : 0


Teva’s Copaxone patent problems continue

Teva Pharmaceuticals Industries Ltd is in trouble again for its multiple sclerosis (MS) injectable drug-Copaxone, as other drug manufacturers seek to launch their own generic versions of the drug. Teva has been fighting patent battles to ward off other pharmaceutical companies from making generic copies of Copaxone.

Copaxone makes up one-fifth of the company’s sales, but it is expected to lose 50% of its revenues by 2016, after its generic copies are launched. To deal ...
Read more : Teva’s Copaxone patent problems continue | Views : 562 | Replies : 1


Lipoatrophy occurrence for MS patients using Copaxone.......

Lipoatrophy occurrence for MS patients using Copaxone higher than originally thought

The risk of developing lipoatrophy for multiple sclerosis (MS) patients administrated with glatiramer acetate is greater than 60 percent, according to a study developed at the Riverside Medical Clinic that reviewed 73 MS patients. It was already known that the drug could cause the condition, however the rate is higher than what was originally thought, according to the study........... Read More - http://www.ms-uk.org/copaxone
Read more : Lipoatrophy occurrence for MS patients using Copaxone....... | Views : 2227 | Replies : 10


Teva sues FDA over bid to block approval of generic Copaxone

Teva Pharmaceutical Industries Ltd. sued U.S. regulators seeking to block approval of a generic version of its multiple-sclerosis drug Copaxone, a product that accounts for more than half the company’s revenue and is set to go off patent on May 24............ Read More - http://www.ms-uk.org/copaxone
Read more : Teva sues FDA over bid to block approval of generic Copaxone | Views : 789 | Replies : 1


Copaxone at 40 ml

For those who have already switched to the new dosing would you mind sharing any thoughts on it? I am specifically interested in hearing about side effects. I know this is a very new dosing change but would like to hear from anyone who has done it. Thank you.
Read more : Copaxone at 40 ml | Views : 1363 | Replies : 10


 

Login  •  Register


Statistics

Total posts 222366 • Total topics 23096 • Total members 14621


Contact us | Terms of Service